Scientists have a new clue in the mystery of why younger people are getting more colon cancer. It may have to do with a toxin ...

An international collaboration has published groundbreaking research, shedding light on the most significant increase in complexity in the history of life's evolution on Earth: the origin of the ...

Scientists at Cincinnati Children's along with an international team of researchers have discovered a surprising new ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

An international team has identified a potential microbial culprit behind the alarming rise in early-onset colorectal cancer: a bacterial toxin called colibactin. Scientists report that exposure to ...

These strategic additions to the executive leadership team reinforce Blue Mountain’s commitment to growth, innovation, and delivering exceptional value to its customers. Keith Pensabene brings ...

Follows recently released positive Phase II clinical trial data of R327G for acute bacterial skin and skin-structure infections Special Report: Developer of a new class of synthetic anti ...

Bacterial physiology is a scientific discipline ... membrane-proximal configuration during rapid growth, with transcription and translation acting as main drivers of nucleoid organization.

Ferring Pharma has reported what it says is the first positive phase 3 trial of a microbiome therapy – based on healthy bacteria – showing it can reduce recurrences of a serious ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of chronic kidney disease. The genetic bases of the seven pairs of contrasting ...